Silicon Laboratories Inc. | |||
Condensed Consolidated Statements of Cash Flows | |||
(In thousands) | |||
(Unaudited) | |||
| |||
| Nine Months Ended | ||
| September 28,
|
| September 29,
|
Operating Activities |
|
|
|
Net income | $ 9,550 |
| $ 68,446 |
Adjustments to reconcile net income to cash provided by operating activities: |
|
|
|
Depreciation of property and equipment | 12,675 |
| 11,781 |
Amortization of other intangible assets and other assets | 29,891 |
| 33,322 |
Amortization of debt discount and debt issuance costs | 10,031 |
| 9,578 |
Stock-based compensation expense | 40,042 |
| 36,893 |
Deferred income taxes | 24,531 |
| (2,994) |
Changes in operating assets and liabilities: |
|
|
|
Accounts receivable | (2,975) |
| 2,518 |
Inventories | 3,512 |
| 5,066 |
Prepaid expenses and other assets | 23,401 |
| 6,349 |
Accounts payable | 6,419 |
| 8,675 |
Other current liabilities and income taxes | (15,602) |
| (23,814) |
Deferred income, deferred revenue and returns liability | (667) |
| (2,816) |
Other non-current liabilities | (5,957) |
| (7,878) |
Net cash provided by operating activities | 134,851 |
| 145,126 |
|
|
|
|
Investing Activities |
|
|
|
Purchases of available-for-sale investments | (306,645) |
| (253,973) |
Sales and maturities of available-for-sale investments | 268,140 |
| 371,885 |
Purchases of property and equipment | (12,773) |
| (18,267) |
Purchases of other assets | (7,132) |
| (9,088) |
Acquisition of business, net of cash acquired | -- |
| (239,729) |
Net cash used in investing activities | (58,410) |
| (149,172) |
|
|
|
|
Financing Activities |
|
|
|
Payment of debt issuance costs | (1,127) |
| -- |
Repurchases of common stock | (26,716) |
| (24,272) |
Payment of taxes withheld for vested stock awards | (15,693) |
| (18,927) |
Proceeds from the issuance of common stock | 7,108 |
| 6,585 |
Payment of acquisition-related contingent consideration | -- |
| (3,380) |
Net cash used in financing activities | (36,428) |
| (39,994) |
|
|
|
|
Increase (decrease) in cash and cash equivalents | 40,013 |
| (44,040) |
Cash and cash equivalents at beginning of period | 197,043 |
| 269,366 |
Cash and cash equivalents at end of period | $237,056 |
| $225,326 |